Clatterbridge Cancer Centre based in Liverpool will provide a range of highly-specialised cancer care such as pioneering chemotherapy, radiotherapy, immunotherapy and gene therapy.
The hospital has a state-of-the-art, teenage and young adult unit, as well as amenities for bone marrow transplant, day case treatments, diagnostics and imaging, clinical therapies, as well as a range of information and support services.
Situated at Royal Liverpool University Hospital and the University’s main campus for biomedical research, will have massive benefits for cancer sufferers moving forward. Enhancing care for the most complex patients, those with heart, lung and kidney comorbidity conditions, by offering rapid access to medical and surgical specialisms. In addition, patients will have access to cutting-edge clinical trials for new cancer treatments.
Today we're welcoming our inpatients from our Wirral site to our new hospital before our outpatients come for their appointments on Monday. We'd like to take this opportunity to say thank you again to everyone who has helped us open Clatterbridge Cancer Centre – #Liverpool 💚 pic.twitter.com/a9EkfLvtis
— ClatterbridgeCC NHS (@CCCNHS) June 27, 2020
The new setting will be the main pivot in the, Clatterbridge Cancer Centre NHS Foundation Trust’s expanding network of treatment centres, which include its Wirral and Aintree sites, as well as hospitals across Cheshire and Merseyside and community settings.
The hospital will also play a crucial role in the second phase of the NHS response to the coronavirus pandemic by offering dedicated spaces for cancer care. CCC-L (Clatterbridge Cancer Centre-Liverpool) will see the NHS in Cheshire and Merseyside well placed to resume normal clinical activity through the provision of protected facilities for cancer patients, many of whom are particularly at risk if they catch coronavirus. As a by-product, this will also free up resources in hospitals throughout the region.
The new cancer facility boasts 110 fully-single en-suite rooms which will help reduce the risk of catching COVID-19, as those with cancer can be at greater risk of becoming unwell from the virus. Additionally, there are special isolation places for patients whose immune systems may be compromised, leaving them particularly vulnerable to infection.
Dr Liz Bishop, Chief Executive of The Clatterbridge Cancer Centre NHS Foundation Trust, said: “Clatterbridge Cancer Centre – Liverpool is the culmination of an eight-year vision for transforming cancer care in a region with one of the highest rates of cancer in the country. It brings state-of-the-art facilities and pioneering cancer treatments to Cheshire and Merseyside at a time when they are more vitally needed than ever. We are tremendously excited about opening Clatterbridge Cancer Centre – Liverpool. It has been a huge labour of love and I would like to pay tribute to our staff, the Laing O’Rourke site team, our suppliers, subcontractors and all the partners who have helped to bring it to fruition.”
The University recently announced the establishment of the LCRI (Liverpool Cancer Research Institute) with a partnership between the region’s three biggest stakeholders in cancer research, the University of Liverpool, The Clatterbridge Cancer Centre NHS Foundation Trust and North West Cancer Research, at the heart of the endeavour.
Did you find this article interesting? You may like this: